$117.90
2.06 (-1.72%)
Last updated: Apr 16, 2026 02:39
Fundamentals Overview
Merck & Co., Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Intrinsic value (DCF)
+37.5% upside vs price
Profitability
Risk (Beta)
0.28 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +37.5% upside vs price · Analyst grade: A- · 3M vs S&P 500: +7.3% · 3M vs Healthcare sector: +14.1%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: mixed. Current institutional positions: Buy: 7, Equal Weight: 4, Hold: 5, Neutral: 6, Outperform: 3, Overweight: 4, Sector Outperform: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $162.13; current price is $117.90. That’s a +37.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 16.07 |
| DCF value (model) | $162.13 (37.5% upside) |
| PEG (TTM) | 2.42 |
| P/B (TTM) | 5.58 |
| P/S (TTM) | 4.48 |
| P/FCF (TTM) | 23.58 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.54 |
| Quick Ratio (TTM) | 1.3 |
| Cash Ratio (TTM) | 0.51 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 28.08% |
| Gross margin (TTM) | 81.5% |
| Operating margin (TTM) | 41.19% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for MRK.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| JP Morgan | maintain | Overweight | Overweight | 2026-04-06 |
| RBC Capital | maintain | Outperform | Outperform | 2026-03-30 |
| Citigroup | maintain | Neutral | Neutral | 2026-03-20 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-03-12 |
| Freedom Broker | maintain | Hold | Hold | 2026-02-09 |
| Guggenheim | maintain | Buy | Buy | 2026-02-06 |
| Citigroup | maintain | Neutral | Neutral | 2026-02-04 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-02-04 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2026-02-04 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-27 |
| TD Cowen | maintain | Hold | Hold | 2026-01-20 |
| Wolfe Research | upgrade | Peer Perform | Outperform | 2026-01-08 |
| UBS | maintain | Buy | Buy | 2026-01-07 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-07 |
| BMO Capital | upgrade | Market Perform | Outperform | 2025-12-18 |
| B of A Securities | maintain | Buy | Buy | 2025-12-15 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-12-12 |
| Scotiabank | maintain | Sector Outperform | Sector Outperform | 2025-12-04 |
| Goldman Sachs | maintain | Buy | Buy | 2025-12-02 |
| Wells Fargo | upgrade | Equal Weight | Overweight | 2025-11-24 |
| Deutsche Bank | maintain | Hold | Hold | 2025-11-18 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-11-03 |
| Berenberg | downgrade | Buy | Hold | 2025-09-17 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-07-30 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-07-10 |
| Citigroup | downgrade | Buy | Neutral | 2025-05-14 |
| Guggenheim | maintain | Buy | Buy | 2025-04-17 |
| Deutsche Bank | downgrade | Buy | Hold | 2025-02-18 |
| Guggenheim | maintain | Buy | Buy | 2025-02-12 |
| Citigroup | maintain | Buy | Buy | 2025-02-05 |